Germany
Japan
United Kingdom
China
Antibodies
View as table Download
BLK Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This BLK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BLK. |
Rabbit Polyclonal ZIPK Antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | ZIP kinase antibody was raised against a peptide corresponding to amino acids near the center of human ZIP kinase. The immunogen is located within amino acids 270 - 320 of ZIPK. |
Rabbit Polyclonal antibody to CaMKII delta (calcium/calmodulin-dependent protein kinase II delta)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 249 and 445 of CaMK2D (Uniprot ID#Q13557) |
Rabbit polyclonal ETK / BMX(Ab-566) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human ETK around the phosphorylation site of tyrosine 566 (D-Q-YP-V-S). |
Rabbit Polyclonal Antibody against BRAF (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This B-RAF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 424-453 amino acids from the Central region of human B-RAF. |
Rabbit polyclonal CSFR (Ab-809) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CSFR around the phosphorylation site of tyrosine 809 (S-N-YP-I-V). |
Rabbit polyclonal p38 MAPK (Ab-322) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human p38 MAPK around the phosphorylation site of tyreonine 322 (D-P-Y-D-Q). |
Rabbit Polyclonal Antibody against DDR1 (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This DDR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 299-330 amino acids from the Central region of human DDR1. |
Rabbit Polyclonal Antibody against AKT2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This AKT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 93-123 amino acids from the N-terminal region of human AKT2. |
Rabbit Polyclonal antibody to FAST (Fas-activated serine/threonine kinase)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 346 and 549 of FAST (Uniprot ID#Q14296) |
Rabbit polyclonal COT (Ab-290) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human COT around the phosphorylation site of threonine 290 (R-G-TP-E-I). |
Rabbit polyclonal Ret (Ab-905) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Ret around the phosphorylation site of tyrosine 905 (D-S-YP-V-K). |
Rabbit polyclonal ALK (Tyr1604) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human ALK around the phosphorylation site of tyrosine 1604 (G-H-YP-E-D). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against FRAP1 (S2481)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This mTOR (FRAP1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 2459-2488 amino acids from human mTOR (FRAP1). |
Rabbit polyclonal PDGFR beta (Ab-1021) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PDGFR β around the phosphorylation site of tyrosine 1021 (N-D-YP-I-I). |
Rabbit polyclonal Raf1 (Ab-621) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human RAF1 around the phosphorylation site of serine 621 (S-A-S-E-P). |
Rabbit polyclonal Akt (Ab-129) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of serine 129 (D-N-SP-G-A). |
Rabbit polyclonal Akt (Ab-326) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of tyrosine 326 (N-D-YP-G-R). |
Active filters
Category
- Antibodies
Reactivities
- Human
Applications
- IF
Families
- Protein Kinase
Availabilities
- In Stock
Filter by
Target Symbol
- MAP2K1 (77)
- MAP2K3 (51)
- ERBB2 (35)
- MAPK13 (34)
- BTK (16)
- AKT1 (14)
- BRAF (14)
- BUB1B (13)
- CDK2 (13)
- FGFR2 (12)
- LIMK1 (12)
- PDGFRB (12)
- MAPK7 (11)
- PRKCE (11)
- PRKD2 (8)
- RET (8)
- CHEK2 (7)
- EGFR (7)
- MAP2K2 (7)
- PIM2 (7)
- PRKY (7)
- PTK2 (7)
- ROS1 (7)
- TYRO3 (7)
- MAP2K4 (6)
- MAPK9 (6)
- STK39 (6)
- FRK (5)
- MAPK1 (5)
- MAPK4 (5)
- NEK6 (5)
- PTK7 (5)
- RPS6KB1 (5)
- TRIM28 (5)
- AKT2 (4)
- ALK (4)
- DAPK2 (4)
- NEK11 (4)
- PKMYT1 (4)
- AKT3 (3)
- AURKC (3)
- MAPK8 (3)
- MET (3)
- NTRK2 (3)
- PASK (3)
- PRKG1 (3)
- RIOK2 (3)
- TRIB2 (3)
- BCKDK (2)
- BMX (2)
- CDK5 (2)
- EPHA2 (2)
- FGFR3 (2)
- LIMK2 (2)
- MAPK3 (2)
- MAPK6 (2)
- MTOR (2)
- NEK9 (2)
- NTRK3 (2)
- PHKG2 (2)
- STK38L (2)
- TRIM33 (2)
- ACVR1C (1)
- ACVRL1 (1)
- BLK (1)
- CAMK1D (1)
- CAMK2D (1)
- CAMKV (1)
- CDK1 (1)
- CDKL4 (1)
- CLK1 (1)
- COQ8B (1)
- CSF1R (1)
- CSK (1)
- CSNK1A1 (1)
- CSNK1A1L (1)
- DAPK3 (1)
- DDR1 (1)
- EIF2AK3 (1)
- EPHA1 (1)
- EPHB1 (1)
- EPHB6 (1)
- ERBB3 (1)
- FASTK (1)
- FGR (1)
- GRK6 (1)
- HSPB8 (1)
- ICK (1)
- JAK1 (1)
- JAK2 (1)
- KDR (1)
- LMTK2 (1)
- LRRK2 (1)
- MAP3K1 (1)
- MAP3K20 (1)
- MAP3K5 (1)
- MAP3K8 (1)
- MAP4K4 (1)
- MAPK11 (1)
- MAPK14 (1)
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Pathways
- MAPK signaling pathway (285)
- Pathways in cancer (245)
- Fc epsilon RI signaling pathway (243)
- GnRH signaling pathway (216)
- Toll-like receptor signaling pathway (215)
- Prostate cancer (208)
- ErbB signaling pathway (201)
- Focal adhesion (195)
- Neurotrophin signaling pathway (193)
- Progesterone-mediated oocyte maturation (185)
- Pancreatic cancer (173)
- Endometrial cancer (169)
- Non-small cell lung cancer (169)
- Regulation of actin cytoskeleton (162)
- T cell receptor signaling pathway (157)
- VEGF signaling pathway (157)
- Bladder cancer (155)
- Colorectal cancer (152)
- Glioma (149)
- Melanoma (149)
- Insulin signaling pathway (146)
- Acute myeloid leukemia (141)
- Fc gamma R-mediated phagocytosis (137)
- Chemokine signaling pathway (133)
- Renal cell carcinoma (131)
- B cell receptor signaling pathway (129)
- Chronic myeloid leukemia (128)
- Gap junction (127)
- Vascular smooth muscle contraction (122)
- Thyroid cancer (113)
- Long-term depression (109)
- Long-term potentiation (108)
- Natural killer cell mediated cytotoxicity (106)
- Oocyte meiosis (106)
- Melanogenesis (94)
- Prion diseases (92)
- Dorso-ventral axis formation (91)
- Amyotrophic lateral sclerosis (ALS) (88)
- Epithelial cell signaling in Helicobacter pylori infection (62)
- Calcium signaling pathway (59)
- Adherens junction (54)
- NOD-like receptor signaling pathway (52)
- mTOR signaling pathway (51)
- RIG-I-like receptor signaling pathway (46)
- Leukocyte transendothelial migration (43)
- Small cell lung cancer (41)
- Cell cycle (40)
- Axon guidance (39)
- Endocytosis (37)
- Adipocytokine signaling pathway (34)
- Tight junction (34)
- Type II diabetes mellitus (30)
- Cytokine-cytokine receptor interaction (25)
- Jak-STAT signaling pathway (23)
- Apoptosis (22)
- p53 signaling pathway (21)
- Primary immunodeficiency (16)
- TGF-beta signaling pathway (14)
- Wnt signaling pathway (14)
- Alzheimer's disease (10)
- Olfactory transduction (5)
- Hedgehog signaling pathway (3)
- Dilated cardiomyopathy (1)
- Hematopoietic cell lineage (1)
- Non-homologous end-joining (1)
- Parkinson's disease (1)
- Regulation of autophagy (1)
- Taste transduction (1)
- Ubiquitin mediated proteolysis (1)
- Vibrio cholerae infection (1)